- Home
- DTIL vs CALC Comparison
DTIL vs CALC Comparison
Compare DTIL & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- CALC
- Stock Information
- Founded
- DTIL 2006
- CALC 2011
- Country
- DTIL United States
- CALC United States
- Employees
- DTIL N/A
- CALC N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- DTIL Health Care
- CALC Health Care
- Exchange
- DTIL Nasdaq
- CALC Nasdaq
- Market Cap
- DTIL 43.3M
- CALC 36.0M
- IPO Year
- DTIL 2019
- CALC N/A
- Fundamental
- Price
- DTIL $4.49
- CALC $1.84
- Analyst Decision
- DTIL Strong Buy
- CALC Strong Buy
- Analyst Count
- DTIL 3
- CALC 3
- Target Price
- DTIL $37.67
- CALC $16.33
- AVG Volume (30 Days)
- DTIL 134.4K
- CALC 75.0K
- Earning Date
- DTIL 03-26-2025
- CALC 05-12-2025
- Dividend Yield
- DTIL N/A
- CALC N/A
- EPS Growth
- DTIL N/A
- CALC N/A
- EPS
- DTIL 1.04
- CALC N/A
- Revenue
- DTIL $68,696,000.00
- CALC N/A
- Revenue This Year
- DTIL N/A
- CALC N/A
- Revenue Next Year
- DTIL $58.46
- CALC N/A
- P/E Ratio
- DTIL $4.32
- CALC N/A
- Revenue Growth
- DTIL 40.98
- CALC N/A
- 52 Week Low
- DTIL $3.61
- CALC $1.81
- 52 Week High
- DTIL $15.97
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- DTIL 38.26
- CALC 42.94
- Support Level
- DTIL $4.25
- CALC $1.81
- Resistance Level
- DTIL $5.72
- CALC $2.21
- Average True Range (ATR)
- DTIL 0.38
- CALC 0.15
- MACD
- DTIL -0.07
- CALC 0.01
- Stochastic Oscillator
- DTIL 16.33
- CALC 47.10
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.